Maintenance of treatment gains up to 12-months following a three-week cognitive processing therapy-based intensive PTSD treatment programme for veterans

Autor: Michael B. Brennan, Victoria L. Steigerwald, Rebecca Van Horn, Jenna M. Bagley, Alyson K. Zalta, Michelle L. Miller, Mark H. Pollack, Philip Held, Dale L. Smith, Randy A. Boley
Jazyk: angličtina
Rok vydání: 2020
Předmět:
强化治疗
050103 clinical psychology
medicine.medical_specialty
随访
seguimiento
Clinical Sciences
TEPT
RC435-571
veteranos
03 medical and health sciences
0302 clinical medicine
Clinical Research
hemic and lymphatic diseases
Behavioral and Social Science
follow-up
Medicine
Psychology
ptsd
0501 psychology and cognitive sciences
veterans
Psychiatry
Depression (differential diagnoses)
• Intensive treatment programmes (ITPs) deliver treatment over the course of 1-3 weeks and show promise for reducing PTSD and depression symptoms. • This study showed that symptom reductions achieved during an ITP can be maintained for up to 12 months after treatment completion
tratamiento intensivo
Clinical Research Article
Depression
business.industry
Intensive treatment
创伤后认知
05 social sciences
Posttraumatic cognitions
PTSD
Post-Traumatic Stress Disorder (PTSD)
Anxiety Disorders
intensive treatment
Brain Disorders
030227 psychiatry
退伍军人
Mental Health
Ptsd treatment
Cognitive processing therapy
posttraumatic cognitions
business
Mind and Body
Research Article
cogniciones postraumáticas
Zdroj: European Journal of Psychotraumatology, Vol 11, Iss 1 (2020)
European Journal of Psychotraumatology
article-version (VoR) Version of Record
European journal of psychotraumatology, vol 11, iss 1
ISSN: 2000-8066
Popis: BackgroundIntensive treatment programmes (ITPs) have shown promise for reducing PTSD and depression symptoms. It is still unknown whether treatment gains are maintained following completion.ObjectiveThis study examined whether veterans were able to maintain treatment gains for up to 12months after an ITP for PTSD and whether reductions in negative posttrauma cognitions predicted treatment gain maintenance.Methods209 veterans (62.7% male, mean age=40.86years) completed a 3-week, CPT-based ITP for PTSD. Participants' PTSD (PCL-5) and depression (PHQ-9) symptoms were assessed at pre-treatment, post-treatment, and at 3-, 6-, and 12-month follow-up timepoints.ResultsDespite small symptom increases from post-treatment to 3-month follow-up, significant and clinically meaningful reductions in PTSD and depression symptoms were reported from intake to 12months follow-up (averaging >18 points on the PCL-5 and >6 points on the PHQ-9; d =1.28, and d =1.18, respectively). Greater reductions in negative posttrauma cognitions during treatment were associated with lower PTSD (p
Databáze: OpenAIRE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje